MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer

British Journal of Radiology

Volumn 88, Issue 1051, 2015, Pages

  Seierstad, T ^a   Hole, K H ^a,b   Groholt K K ^a   Dueland, S ^a   Ree, A H ^b,c   Flatmark, K ^a   Redalen, K R ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER LOCALIZATION; CANCER REGRESSION; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PHASE 2 CLINICAL TRIAL; PREDICTION; PREDICTIVE VALUE; PREOPERATIVE CARE; PROSPECTIVE STUDY; RADIATION RESPONSE; RADIOTHERAPY PLANNING SYSTEM; RECTUM CANCER; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; VOLUMETRY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CHEMORADIOTHERAPY; MIDDLE AGED; PATHOLOGY; RECTAL NEOPLASMS; TUMOR VOLUME; YOUNG ADULT;

ADULT; AGED; CHEMORADIOTHERAPY; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM GRADING; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; TUMOR BURDEN; YOUNG ADULT;

EID: 84937921313     PISSN: 00071285     EISSN: 1748880X     Source Type: Journal    
DOI: 10.1259/bjr.20150097     Document Type: Article

References (32)

1. Weber GF, Rosenberg R, Murphy JE, Meyer Zum Büschenfelde C, Friess H. Multimodal treatment strategies for locally advanced rectal cancer. Expert Rev Anticancer Ther 2012; 12: 481-94. doi: 10.1586/era.12.3
2. Chua YJ, Barbachano Y, Cunningham D, Oates JR, Brown G, Wotherspoon A, et al. Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial. Lancet Oncol 2010; 11: 241-8. doi: 10.1016/s1470-2045 (09)70381-x
3. Chau I, Brown G, Cunningham D, Tait D, Wotherspoon A, Norman AR, et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 2006; 24: 668-74. doi: 10.1200/jco.2005.04.4875
4. Schou JV, Larsen FO, Rasch L, Linnemann D, Langhoff J, Høgdall E, et al. Induction chemotherapy with capecitabine and oxaliplatin followed by chemoradiotherapy before total mesorectal excision in patients with locally advanced rectal cancer. Ann Oncol 2012; 23: 2627-33. doi: 10.1093/annonc/mds056
5. Engelen SM, Maas M, Lahaye MJ, Leijtens JW, van Berlo CL, Jansen RL, et al. Modern multidisciplinary treatment of rectal cancer based on staging with magnetic resonance imaging leads to excellent local control, but distant control remains a challenge. Eur J Cancer 2013; 49: 2311-20. doi: 10.1016/j.ejca.2013.03.006
6. Schrag D, Weiser MR, Goodman KA, Gonen M, Hollywood E, Cercek A, et al. Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. J Clin Oncol 2014; 32: 513-18. doi: 10.1200/JCO.2013.51.7904
7. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-47. doi: 10.1016/j.ejca.2008.10.026
8. Wang JZ, Mayr NA, Zhang D, Li K, Grecula JC, Montebello JF, et al. Sequential magnetic resonance imaging of cervical cancer: the predictive value of absolute tumour volume and regression ratio measured before, during, and after radiation therapy. Cancer 2010; 116: 5093-101. doi: 10.1002/cncr.25260
9. Schrag D. Evolving role of neoadjuvant therapy in rectal cancer. Curr Treat Options Oncol 2013; 14: 350-64. doi: 10.1007/s11864- 013-0242-8
10. Curvo-Semedo L, Lambregts DM, Maas M, Thywissen T, Mehsen RT, Lammering G, et al. Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy-conventional MR volumetry versus diffusion-weighted MR imaging. Radiology 2011; 260: 734-43. doi: 10.1148/radiol.11102467
11. Barbaro B, Fiorucci C, Tebala C, Valentini V, Gambacorta MA, Vecchio FM, et al. Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology 2009; 250: 730-9. doi: 10.1148/radiol.2503080310
12. Yeo SG, Kim DY, Kim TH, Jung KH, Hong YS, Chang HJ, et al. Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumour response of preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2010; 78: 164-71. doi: 10.1016/j.ijrobp.2009.07.1682
13. Yeo SG, Kim DY, Kim TH, Chang HJ, Oh JH, Park W, et al. Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01). Ann Surg 2010; 252: 998-1004. doi: 10.1097/SLA.0b013e3181f3f1b1
14. Nougaret S, Rouanet P, Molinari N, Pierredon MA, Bibeau F, Azria D, et al. MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy. Radiology 2012; 263: 409-18. doi: 10.1148/radiol.12111263
15. Jakobsen A, Ploen J, Vuong T, Appelt A, Lindebjerg J, Rafaelsen SR. Dose-effect relationship in chemoradiotherapy for locally advanced rectal cancer: a randomized trial comparing two radiation doses. Int J Radiat Oncol Biol Phys 2012; 84: 949-54. doi: 10.1016/j.ijrobp.2012.02.006
16. Nougaret S, Fujii S, Addley HC, Bibeau F, Pandey H, Mikhael H, et al. Neoadjuvant chemotherapy evaluation by MRI volumetry in rectal cancer followed by chemoradiation and total mesorectal excision: initial experience. J Magn Reson Imaging 2013; 38: 726-32. doi: 10.1002/jmri.23905
17. Aiba T, Uehara K, Nihashi T, Tsuzuki T, Yatsuya H, Yoshioka Y, et al. MRI and FDGPET for assessment of response to neoadjuvant chemotherapy in locally advanced rectal cancer. Ann Surg Oncol 2014; 21: 1801-8. doi: 10.1245/s10434-014-3538-4
18. Bernstein TE, Endreseth BH, Romundstad P, Wibe A; Norwegian Colorectal Cancer Group. Circumferential resection margin as a prognostic factor in rectal cancer. Br J Surg 2009; 96: 1348-57. doi: 10.1002/bjs.6739
19. Brown G, Richards CJ, Newcombe RG, Dallimore NS, Radcliffe AG, Carey DP, et al. Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology 1999; 211: 215-22. doi: 10.1148/radiology.211.1. r99ap35215
20. Brown G, Richards CJ, Bourne MW, Newcombe RF, Radcliffe AG, Dallimore NS, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatialresolution MR imaging with histopathologic comparison. Radiology 2003; 227: 371-7. doi: 10.1148/radiol.2272011747
21. MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006; 333: 779. doi: 10.1136/bmj.38937.646400.55
22. Hole KH, Larsen SG, Grøholt KK, Giercksky KE, Ree AH. Magnetic resonance-guided histopathology for improved accuracy of tumor response evaluation of neoadjuvant treatment in organ-infiltrating rectal cancer. Radiother Oncol 2013; 107: 178-83. doi: 10.1016/j.radonc.2013.03.017
23. Bouzourene H, Bosman FT, Seelentag W, Matter M, Coucke P. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 2012; 94: 1121-30. doi: 10.1002/cncr.10327
24. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997; 12: 19-23. doi: 10.1007/s003840050072
25. Valentini V, Minsky BD. Tumor regression grading in rectal cancer: is it time to move forward? J Clin Oncol 2014; 32: 1534-6. doi: 10.1200/JCO.2014.55.4766
26. Habr-Gama A, Sabbaga J, Gama-Rodrigues J, São Julião GP, Proscurshim I, Bailão Aguilar P, et al. Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management? Dis Colon Rectum 2013; 56: 1109-17. doi: 10.1097/DCR.0b013e3182a25c4e
27. Fokas E, Liersch T, Fietkau R, Hohenberger W, Beissbarth T, Hess C, et al. Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial. J Clin Oncol 2014; 32: 1554-62. doi: 10.1200/jco.2013.54.3769
28. Wu LM, Zhu J, Hu J, Yin Y, Gu HY, Hua J, et al. Is there a benefit in using magnetic resonance imaging in the prediction of preoperative neoadjuvant therapy response in locally advanced rectal cancer? Int J Colorectal Dis 2013; 28: 1225-38. doi: 10.1007/s00384-013-1676-y
29. Beets-Tan RG, Beets GL. MRI for assessing and predicting response to neoadjuvant treatment in rectal cancer. Nat Rev Gastroenterol Hepatol 2014; 11: 480-8. doi: 10.1038/nrgastro.2014.41
30. Joye I, Deroose CM, Vandecaveye V, Haustermans K. The role of diffusionweighted MRI and (18)F-FDG PET/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: a systematic review. Radiother Oncol 2014; 113: 158-65. doi: 10.1016/j.radonc.2014.11.026
31. Petrillo A, Fusco R, Petrillo M, Granata V, Sansone M, Avallone A, et al. Standardized Index of Shape (SIS): a quantitative DCEMRI parameter to discriminate responders by non-responders after neoadjuvant therapy in LARC. Eur Radiol Jan 2015. Epub ahead of print. doi: 10.1007/s00330-014-3581-3
32. Janssen MH, Öllers MC, van Stiphout RG, Riedl RG, van den Bogaard J, Buijsen J, et al. PET-based treatment response evaluation in rectal cancer: prediction and validation. Int J Radiat Oncol Biol Phys 2012; 82: 871-6. doi: 10.1016/j.ijrobp.2010.11.038